MEDICINE DETAILS
Rubraca
Active ingredient: Rucaparib
Neutral reference profile for an independent medicine-access consultancy enquiry about Rubraca (Rucaparib). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Rubraca used for?
Rubraca (rucaparib) is indicated as monotherapy for:
The treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer, who have been treated with two or more chemotherapies. Patients should be selected for therapy based on the FDA-approved FoundationFocus CDxBRCA test (Foundation Medicine Inc.). Approximately 15 to 20% of patients with ovarian cancer have a BRCA gene mutation.
The maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Rubraca identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
200 mg · 60 tablets Catalogue organisation: pharmaand GmbH
-
250 mg · 60 tablets Catalogue organisation: pharmaand GmbH
-
300 mg · 60 tablets Catalogue organisation: pharmaand GmbH
OFFICIAL SOURCES
Check the Rubraca record at an official source.
Search for “Rubraca” or “Rucaparib”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Rubraca.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Rubraca
01What is Rubraca?＋
This directory record associates the brand name Rubraca with the active ingredient Rucaparib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Rubraca strengths and packs are recorded?＋
The catalogue currently shows: 200 mg · 60 tablets; 250 mg · 60 tablets; 300 mg · 60 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Rubraca?＋
Catalogue records currently name: pharmaand GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Rubraca?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Rubraca, payment request, stock guarantee or binding offer.
06Can I buy Rubraca from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.